CD-001

West China Hospital · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	CD-001
Sponsor	West China Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers (PHASE1)
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Solid Tumors (PHASE1)
Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CD-001 CI brief — competitive landscape report
CD-001 updates RSS · CI watch RSS
West China Hospital portfolio CI